Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10:30 | SONDERMELDUNG: Könnte die Formycon-Aktie jetzt komplett drehen - Das müssen Sie UNBEDINGT beachten! | Hebelschein-Spekulant | |||
09:09 | SMOLTEK NANOTECH HOLDING AB: Smoltek's rights issue was subscribed to 86.4 percent without the use of underwriting commitments and the company receives SEK 22.4 million | 1 | Cision News | ||
Di | Kopin to develop novel AR optics for U.S. Army under new SBIR contract | 4 | Seeking Alpha | ||
Di | SMOLTEK NANOTECH HOLDING AB: Smoltek announces preliminary outcome in rights issue which indicates that the minimum level is reached | 3 | Cision News | ||
Di | REGION GROUP: Dividend/Distribution - RGN | - | ASX | ||
Di | REGION GROUP: June 2024 Transactions and Property Valuations Update | - | ASX | ||
Di | REGION GROUP: RGN Final FY24 Distribution | - | ASX | ||
Mo | Rennova Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Sa | Unglaubliche Prognose für Montag setzt Formycon Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! copy | Felix Haupt | |||
Fr | Here's How Much $100 Invested In Onto Innovation 5 Years Ago Would Be Worth Today | 1 | Benzinga.com | ||
Fr | Nanoform Finland Plc - Manager's Transactions - Miguel Calado | 1 | Cision News | ||
Fr | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 1 | Cision News | ||
Fr | Nanoform Finland Plc - Manager's Transactions - Mads Laustsen | 1 | Cision News | ||
Fr | Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma | 1 | Cision News | ||
Fr | Share subscriptions based on the resolution by Nanoform Finland Plc's Annual General Meeting 2024 on remuneration of the Board of Directors | 1 | Cision News | ||
Fr | FOXO Technologies Inc.: FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. | 2 | GlobeNewswire (USA) | ||
Fr | Formycon: Start of clinical development program for FYB206; mwb research reiterates to BUY | 444 | mwb research | Formycon AG has achieved another milestone with the launch of the FYB206 Phase I clinical trial. This trial marks the beginning of clinical testing for Formycon's biosimilar to Merck & Co.'s Keytruda... ► Artikel lesen | |
Fr | Smoltek: We have technology to make green hydrogen production profitable | 2 | Offshore Energy Today | ||
Do | (ONTO) - Analyzing Onto Innovation's Short Interest | 2 | Benzinga.com | ||
Do | EQS-News: Formycon AG: Formycon informiert über die Ergebnisse der ordentlichen Hauptversammlung | 467 | EQS Group (DE) | EQS-News: Formycon AG
/ Schlagwort(e): Hauptversammlung/Sonstiges
Formycon informiert über die Ergebnisse der ordentlichen Hauptversammlung
13.06.2024 / 15:30 CET/CEST
Für... ► Artikel lesen |
Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
---|---|---|---|---|---|---|---|---|---|
Es sind keine Aktien verfügbar, die den gewählten Kriterien entsprechen. |